|SEQ_NO||1||Date of announcement||2020/05/13||Time of announcement||16:41:17|
|Subject||Announcement of TTY Biopharm's unaudited income information in April 2020|
|Date of events||2020/05/13||To which item it meets||paragraph 53|
|Statement||1.Date of occurrence of the event:2020/05/13
2.Company name:TTY Biopharm Co., Ltd.
3.Relationship to the Company (please enter ”head office” or ”subsidiaries”):Head office
4.Reciprocal shareholding ratios:N/A
5.Cause of occurrence:TTY Biopharm posted a consolidated net sales of $356,006 thousands(expressed in NT dollars; unaudited), a consolidated operating profit of $99,139 thousands, and a consolidated income before tax of $99,063 thousands in Apr 2020; net income attributed to stockholders of the company was $77,171 thousands; EPS is $0.31.
Year-to-date consolidated net sales was $1,449,473 thousands (in NT dollars; unaudited), a consolidated operating profit was $382,893 thousands and consolidated income before tax was $422,704 thousands until Apr 2020; year-to-date net income attributed to stockholders of the company was $330,743 thousands; EPS is $1.33.
7.Any other matters that need to be specified:The numbers above are unaudited. In term of the final net sales and profits, quarterly financial reports audited by independent accountants will prevail.